Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.64 |
| ▸ | SQLE | Q14534 | 7/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | FNTA | P49354 | 1/20 | 0.52 |
| ▸ | FNTB | P49356 | 1/20 | 0.52 |
| ▸ | ICMT | O60725 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9238573 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL158266 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL255003 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL16485660 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL1586840 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL2250076 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL158315 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL11844736 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL11844741 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 | |
| SCHEMBL12293765 | 1.00 | KMT2A (0.73) | KMT2AMAPTMEN1CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600703-B2 | Methods of synthesizing farnesyl dibenzodiazepinones | AMO PHARMA LTD. (GB) | 2026-04-14 | — | — | US | claimed |
| US-20230192629-A1 | METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONES | AMO PHARMA LTD. (US) | 2023-06-22 | — | — | US | claimed |
| EP-4157283-A1 | METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONES | Amo Pharma Ltd. (US) | 2023-04-05 | — | — | EP | claimed |
| CN-115835869-A | Process for the synthesis of nifedibenzodiazepinone | 阿默制药有限公司 | 2023-03-21 | — | — | CN | claimed |
| WO-2021243171-A1 | METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONES | AMO PHARMA LTD (US) | 2021-12-02 | — | — | WO | claimed |
| CN-108627647-B | Detection and quantification method of post-translational modification proteomics | 四川大学 | 2020-06-19 | — | — | CN | claimed |
| CN-107417771-A | A kind of preparation method of the cysteine polypeptide of farnesyl modification | 苏州强耀生物科技有限公司 | 2017-12-01 | — | — | CN | claimed |
| WO-2009094534-A1 | IMPROVED METHOD FOR PREPARING ISOPRENYL CYSTEINE COMPOUNDS AND ANALOGS THEREOF | SIGNUM BIOSCIENCES, INC. (US) | 2009-07-30 | — | — | WO | claimed |
| US-20090192332-A1 | Method for Preparing Isoprenyl Cysteine Compounds and Analogs Thereof | RAPOLE KESHAVA | 2009-07-30 | — | — | US | claimed |
| CN-1325648-C | Improved fermentative carotenoid production | HOFFMANN LA ROCHE (NL) | 2007-07-11 | — | — | CN | claimed |
| US-6267945-B1 | AADMINSTERING FARNESOL RELATED COMPOUND FOR TREATING CONDITIONS ASSOCIATED WITH N-TYPE CALCIUM CHANNEL ACTIVITY | NEUROMED TECHNOLOGIES, INC. (CA) | 2001-07-31 | — | — | US | claimed |
| US-4503240-A | Process for preparing 8,12-epoxy-13,14,15,16-tetranorlabdane | Consortium F/u/ r Elektrochemische Industrie GmbH (DE) | 1985-03-05 | — | — | US | claimed |
| US-4229356-A | Production of vitamin K1 and vitamin K2 | WAKUNAGA YAKUHIN KABUSHIKI KAISHA (JP) | 1980-10-21 | — | — | US | claimed |
| JP-55028948-A | — | — | None | — | — | JP | disclosed |
| JP-62005996-A | — | — | None | — | — | JP | disclosed |
| JP-62005995-A | — | — | None | — | — | JP | disclosed |
| US-4028385-A | RECTIFICATION | KURARAY CO., LTD. (JA) | 1977-06-07 | — | — | US | disclosed |
| US-4001339-A | INSECTICIDES | HOFFMANN-LA ROCHE INC. (US) | 1977-01-04 | — | — | US | disclosed |
| US-3983177-A | FROM UNSATURATED HALIDE AND ESTER | RHONE-POULENC S.A. (FR) | 1976-09-28 | — | — | US | disclosed |
| US-3944531-A | P-ALKOXY-BENZALDEHYDES, INSECTICIDE | HOFFMANN-LA ROCHE INC. (US) | 1976-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090192332-A1 | Method for Preparing Isoprenyl Cysteine Compounds and Analogs Thereof | LCAT, LIPA, GPX4 | KMT2A 4327/4885MAPT 4815/4885MEN1 4075/4885 |
| US-20230192629-A1 | METHODS OF SYNTHESIZING FARNESYL DIBENZODIAZEPINONES | FNTB, FNTA, FDPS | KMT2A 2803/4885MAPT 2499/4885MEN1 81/4885 |
| US-12600703-B2 | Methods of synthesizing farnesyl dibenzodiazepinones | NR1H2, NR1H3, NR1H4 | KMT2A 2873/4885MAPT 3916/4885MEN1 1587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.